Bezawit A. Woldemeskel

SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

Bezawit A. Woldemeskel, Caroline C. Garliss, Joel N. Blankson · Journal of Clinical Investigation · 2021 · 183 citations · Full text

Vaccination, Sars-cov-2 Variants, Spike Protein +13

The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)

Bezawit A. Woldemeskel, Andrew H. Karaba, Caroline C. Garliss et al. · Clinical Infectious Diseases · 2021 · 146 citations · Full text

Humoral Response, Immunology, Human Immunodeficiency Virus +19

Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses

Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel et al. · Journal of Clinical Investigation · 2021 · 92 citations · Full text

Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2

Bezawit A. Woldemeskel, Abena K. Kwaa, Caroline C. Garliss et al. · Journal of Clinical Investigation · 2020 · 87 citations · Full text

Targeted Peptides, T Cell Responses, Common Cold Coronaviruses +13

CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses

Bezawit A. Woldemeskel, Arbor G. Dykema, Caroline C. Garliss et al. · Journal of Clinical Investigation · 2022 · 30 citations · Full text

Immunology, Cd4 T Cell Responses, Viral Structural Protein +17